XFOR earnings
X4 Pharmaceuticals (XFOR) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
- XFOR beat EPS estimates in 5 of its last 13 reports.
XFOR earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q3 2026 | Nov 4, 2026 | -0.16 | -0.17 | 4.76% | $2.88M |
| Q2 2026 | Aug 6, 2026 | -0.13 | – | – | $8.81M |
| Q1 2026 | May 6, 2026 | -0.16 | -0.20 | 20.00% | $2.71M |
| Q4 2025 | Mar 17, 2026 | -0.22 | -0.36 | 38.89% | $2.57M |
| Q3 2025 | Nov 5, 2025 | -0.69 | -0.79 | 12.66% | $1.76M |
| Q2 2025 | Aug 8, 2025 | -3.47 | -4.53 | 23.40% | $1.97M |
| Q1 2025 | May 1, 2025 | 0.04 | – | – | $28.81M |
| Q4 2024 | Mar 25, 2025 | -6.01 | -5.11 | -17.61% | $1.43M |
| Q3 2024 | Nov 13, 2024 | -5.41 | – | – | $560.00K |
| Q2 2024 | Aug 8, 2024 | -2.10 | – | – | $563.00K |
| Q1 2024 | May 7, 2024 | -7.81 | -0.17 | -4494.12% | $0.00 |
| Q4 2023 | Mar 21, 2024 | -3.00 | -0.15 | -1900.00% | $0.00 |
| Q3 2023 | Nov 9, 2023 | -0.30 | -0.15 | -100.00% | $0.00 |
| Q2 2023 | Aug 10, 2023 | -9.91 | -0.17 | -5729.41% | $0.00 |
| Q1 2023 | May 4, 2023 | -4.80 | -0.22 | -2081.82% | – |
| Q4 2022 | Mar 21, 2023 | -8.71 | -0.27 | -3125.93% | – |
| Q3 2022 | Nov 3, 2022 | -7.81 | -0.30 | -2503.33% | – |